Inhibition of adenosine kinase attenuates inflammation and neurotoxicity in traumatic optic neuropathy

Saif Ahmad, Nehal M. Elsherbiny, Kanchan Bhatia, Ahmed M. Elsherbini, Sadanand T Fulzele, Gregory I Liou

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Traumatic optic neuropathy (TON) is associated with apoptosis of retinal ganglion cells. Local productions of reactive oxygen species and inflammatory mediators from activated microglial cells have been hypothesized to underlie apoptotic processes. We previously demonstrated that the anti-inflammatory effect of adenosine, through A2A receptor activation had profound protective influence against retinal injury in traumatic optic neuropathy. This protective effect is limited due to rapid cellular re-uptake of adenosine by equilibrative nucleotside transporter-1 (ENT1) or break down by adenosine kinase (AK), the key enzyme in adenosine clearance pathway. Further, the use of adenosine receptors agonists are limited by systemic side effects. Therefore, we seek to investigate the potential role of amplifying the endogenous ambient level of adenosine by pharmacological inhibition of AK. We tested our hypothesis by comparing TON-induced retinal injury in mice with and without ABT-702 treatment, a selective AK inhibitor (AKI). The retinal-protective effect of ABT-702 was demonstrated by significant reduction of Iba-1, ENT1, TNF-α, IL-6, and iNOS/nNOS protein or mRNA expression in TON as revealed by western blot and real time PCR. TON-induced superoxide anion generation and nitrotyrosine expression were reduced in ABT-702 treated mice retinal sections as determined by immunoflourescence. In addition, ABT-702 attenuated p-ERK1/2 and p-P38 activation in LPS induced activated mouse microglia cells. The results of the present investigation suggested that ABT-702 had a protective role against marked TON-induced retinal inflammation and damage by augmenting the endogenous therapeutic effects of site- and event-specific accumulation of extracellular adenosine.

Original languageEnglish (US)
Pages (from-to)96-104
Number of pages9
JournalJournal of Neuroimmunology
Volume277
Issue number1-2
DOIs
StatePublished - Dec 15 2014

Fingerprint

Adenosine Kinase
Optic Nerve Injuries
Inflammation
Adenosine
Purinergic P1 Receptor Agonists
Adenosine A2A Receptors
Retinal Ganglion Cells
Wounds and Injuries
Microglia
Therapeutic Uses
Superoxides
Real-Time Polymerase Chain Reaction
Interleukin-6
Reactive Oxygen Species
Anti-Inflammatory Agents
Western Blotting
ABT 702
Pharmacology
Apoptosis
Messenger RNA

Keywords

  • ABT-702
  • Adenosine kinase
  • Inflammation
  • MAPKinase
  • Microglia
  • Traumatic optic neuropathy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

Inhibition of adenosine kinase attenuates inflammation and neurotoxicity in traumatic optic neuropathy. / Ahmad, Saif; Elsherbiny, Nehal M.; Bhatia, Kanchan; Elsherbini, Ahmed M.; Fulzele, Sadanand T; Liou, Gregory I.

In: Journal of Neuroimmunology, Vol. 277, No. 1-2, 15.12.2014, p. 96-104.

Research output: Contribution to journalArticle

Ahmad, Saif ; Elsherbiny, Nehal M. ; Bhatia, Kanchan ; Elsherbini, Ahmed M. ; Fulzele, Sadanand T ; Liou, Gregory I. / Inhibition of adenosine kinase attenuates inflammation and neurotoxicity in traumatic optic neuropathy. In: Journal of Neuroimmunology. 2014 ; Vol. 277, No. 1-2. pp. 96-104.
@article{5bceef7482754a45b9f8995c752c88f5,
title = "Inhibition of adenosine kinase attenuates inflammation and neurotoxicity in traumatic optic neuropathy",
abstract = "Traumatic optic neuropathy (TON) is associated with apoptosis of retinal ganglion cells. Local productions of reactive oxygen species and inflammatory mediators from activated microglial cells have been hypothesized to underlie apoptotic processes. We previously demonstrated that the anti-inflammatory effect of adenosine, through A2A receptor activation had profound protective influence against retinal injury in traumatic optic neuropathy. This protective effect is limited due to rapid cellular re-uptake of adenosine by equilibrative nucleotside transporter-1 (ENT1) or break down by adenosine kinase (AK), the key enzyme in adenosine clearance pathway. Further, the use of adenosine receptors agonists are limited by systemic side effects. Therefore, we seek to investigate the potential role of amplifying the endogenous ambient level of adenosine by pharmacological inhibition of AK. We tested our hypothesis by comparing TON-induced retinal injury in mice with and without ABT-702 treatment, a selective AK inhibitor (AKI). The retinal-protective effect of ABT-702 was demonstrated by significant reduction of Iba-1, ENT1, TNF-α, IL-6, and iNOS/nNOS protein or mRNA expression in TON as revealed by western blot and real time PCR. TON-induced superoxide anion generation and nitrotyrosine expression were reduced in ABT-702 treated mice retinal sections as determined by immunoflourescence. In addition, ABT-702 attenuated p-ERK1/2 and p-P38 activation in LPS induced activated mouse microglia cells. The results of the present investigation suggested that ABT-702 had a protective role against marked TON-induced retinal inflammation and damage by augmenting the endogenous therapeutic effects of site- and event-specific accumulation of extracellular adenosine.",
keywords = "ABT-702, Adenosine kinase, Inflammation, MAPKinase, Microglia, Traumatic optic neuropathy",
author = "Saif Ahmad and Elsherbiny, {Nehal M.} and Kanchan Bhatia and Elsherbini, {Ahmed M.} and Fulzele, {Sadanand T} and Liou, {Gregory I}",
year = "2014",
month = "12",
day = "15",
doi = "10.1016/j.jneuroim.2014.10.006",
language = "English (US)",
volume = "277",
pages = "96--104",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Inhibition of adenosine kinase attenuates inflammation and neurotoxicity in traumatic optic neuropathy

AU - Ahmad, Saif

AU - Elsherbiny, Nehal M.

AU - Bhatia, Kanchan

AU - Elsherbini, Ahmed M.

AU - Fulzele, Sadanand T

AU - Liou, Gregory I

PY - 2014/12/15

Y1 - 2014/12/15

N2 - Traumatic optic neuropathy (TON) is associated with apoptosis of retinal ganglion cells. Local productions of reactive oxygen species and inflammatory mediators from activated microglial cells have been hypothesized to underlie apoptotic processes. We previously demonstrated that the anti-inflammatory effect of adenosine, through A2A receptor activation had profound protective influence against retinal injury in traumatic optic neuropathy. This protective effect is limited due to rapid cellular re-uptake of adenosine by equilibrative nucleotside transporter-1 (ENT1) or break down by adenosine kinase (AK), the key enzyme in adenosine clearance pathway. Further, the use of adenosine receptors agonists are limited by systemic side effects. Therefore, we seek to investigate the potential role of amplifying the endogenous ambient level of adenosine by pharmacological inhibition of AK. We tested our hypothesis by comparing TON-induced retinal injury in mice with and without ABT-702 treatment, a selective AK inhibitor (AKI). The retinal-protective effect of ABT-702 was demonstrated by significant reduction of Iba-1, ENT1, TNF-α, IL-6, and iNOS/nNOS protein or mRNA expression in TON as revealed by western blot and real time PCR. TON-induced superoxide anion generation and nitrotyrosine expression were reduced in ABT-702 treated mice retinal sections as determined by immunoflourescence. In addition, ABT-702 attenuated p-ERK1/2 and p-P38 activation in LPS induced activated mouse microglia cells. The results of the present investigation suggested that ABT-702 had a protective role against marked TON-induced retinal inflammation and damage by augmenting the endogenous therapeutic effects of site- and event-specific accumulation of extracellular adenosine.

AB - Traumatic optic neuropathy (TON) is associated with apoptosis of retinal ganglion cells. Local productions of reactive oxygen species and inflammatory mediators from activated microglial cells have been hypothesized to underlie apoptotic processes. We previously demonstrated that the anti-inflammatory effect of adenosine, through A2A receptor activation had profound protective influence against retinal injury in traumatic optic neuropathy. This protective effect is limited due to rapid cellular re-uptake of adenosine by equilibrative nucleotside transporter-1 (ENT1) or break down by adenosine kinase (AK), the key enzyme in adenosine clearance pathway. Further, the use of adenosine receptors agonists are limited by systemic side effects. Therefore, we seek to investigate the potential role of amplifying the endogenous ambient level of adenosine by pharmacological inhibition of AK. We tested our hypothesis by comparing TON-induced retinal injury in mice with and without ABT-702 treatment, a selective AK inhibitor (AKI). The retinal-protective effect of ABT-702 was demonstrated by significant reduction of Iba-1, ENT1, TNF-α, IL-6, and iNOS/nNOS protein or mRNA expression in TON as revealed by western blot and real time PCR. TON-induced superoxide anion generation and nitrotyrosine expression were reduced in ABT-702 treated mice retinal sections as determined by immunoflourescence. In addition, ABT-702 attenuated p-ERK1/2 and p-P38 activation in LPS induced activated mouse microglia cells. The results of the present investigation suggested that ABT-702 had a protective role against marked TON-induced retinal inflammation and damage by augmenting the endogenous therapeutic effects of site- and event-specific accumulation of extracellular adenosine.

KW - ABT-702

KW - Adenosine kinase

KW - Inflammation

KW - MAPKinase

KW - Microglia

KW - Traumatic optic neuropathy

UR - http://www.scopus.com/inward/record.url?scp=84918792932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918792932&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2014.10.006

DO - 10.1016/j.jneuroim.2014.10.006

M3 - Article

C2 - 25457840

AN - SCOPUS:84918792932

VL - 277

SP - 96

EP - 104

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -